Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Hepatocellular 14Leukemia, Myeloid, Acute 7Neoplasms 3Neoplasm Metastasis 3Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Neuroblastoma 2Liver Neoplasms 2Hepatoblastoma 2Fibrolamellar hepatocellular carcinoma 2Tongue Neoplasms 1Thyroid cancer, Hurthle cell 1Thyroid Diseases 1Sarcoma, Myeloid 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Recurrence 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasm, Residual 1Myelodysplastic Syndromes 1Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors 1Melanoma 1Gastrointestinal Stromal Tumors 1Desmoplastic Small Round Cell Tumor 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Vincristine 13Temozolomide 12Cyclophosphamide 11Irinotecan 8Magnetic Resonance Spectroscopy 7X-Rays 6Vinorelbine 6Specimen Handling 6Phantoms, Imaging 6Dactinomycin 6Biopsy 5fludarabine 4Radiotherapy 4Radiation 4Nuclear Medicine Department, Hospital 4Filgrastim 4Etoposide 4pegfilgrastim 3irinotecan sucrosofate 3Sirolimus 3Proton Therapy 3Melphalan 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rhabdomyosarcoma × Sorafenib × 1 year × Clear all
NCT01871766 2026-04-24

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
115 enrolled
Sarcoma

Rhabdomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡